These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

(Alliance News) - Syncona Ltd on Wednesday said portfolio company Achilles Therapeutics PLC is planning to return capital to shareholders though a members' solvent voluntary liquidation.

Overview: Achilles Therapeutics plc is a biopharmaceutical company focused on developing precision T cell therapies for the treatment of solid tumors, with a market cap of $46.03 million.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Syncona Ltd on Wednesday said portfolio company Achilles Therapeutics PLC is planning to return capital to shareholders though a members' solvent voluntary liquidation. The London-based investor in ...

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.